Published: Mar 1, 2026
Written by Klarity Editorial Team
Published: Mar 1, 2026

If you’re struggling with binge eating disorder (BED), you might be wondering whether you can access treatment from the comfort of your home. The short answer is yes—telehealth has transformed mental health care, making it easier than ever to get evaluated and treated for BED without stepping into a doctor’s office.
But navigating the world of online prescriptions can feel confusing. What medications are available? Is it legal in your state? Do you need an in-person visit first? This comprehensive guide walks you through everything you need to know about getting BED medication via telehealth in 2026.
Binge eating disorder is the most common eating disorder in the United States, affecting millions of people. It’s characterized by recurrent episodes of eating large amounts of food in a short period (typically within two hours), accompanied by a feeling of losing control. Unlike bulimia, BED doesn’t involve purging behaviors like vomiting or excessive exercise.
To receive a clinical diagnosis of BED, you typically need to experience binge eating episodes at least once a week for three months, along with feelings of distress about the behavior. The condition often co-occurs with depression, anxiety, and weight-related health concerns.
While Vyvanse (lisdexamfetamine) is the only FDA-approved medication specifically for binge eating disorder, it’s a controlled substance (Schedule II stimulant), which comes with stricter prescribing rules—especially for telehealth. As a result, many telehealth providers focus on off-label medications that have shown effectiveness in clinical studies and can be prescribed more easily online.
The two most commonly prescribed non-controlled medications for BED via telehealth are:
Topamax (Topiramate)
Wellbutrin (Bupropion)
Both medications are prescribed off-label for BED, which is a common and legal practice in medicine when evidence supports their use.
One of the biggest questions patients have is whether federal law allows telehealth prescribing for BED medications. The answer depends on whether the medication is a controlled substance.
Good news: Federal law has never required an in-person visit for non-controlled medications prescribed via telehealth. The Ryan Haight Act—the federal law that restricts online prescribing—only applies to controlled substances (like opioids, stimulants, and benzodiazepines).
Since Topamax and Wellbutrin are not controlled substances, providers licensed in your state can legally prescribe them after a telehealth evaluation, with no federal mandate for an in-person exam. This has been the case before, during, and after the COVID-19 pandemic.
The rules are more complex for controlled medications. During the COVID-19 public health emergency, the DEA temporarily waived the in-person requirement for controlled substances prescribed via telehealth. As of January 2026, this flexibility has been extended through December 31, 2026, allowing providers to continue prescribing certain controlled substances via telehealth while permanent regulations are finalized.
However, most legitimate telehealth platforms choose not to prescribe stimulants like Vyvanse for BED due to abuse potential and regulatory uncertainty. If your provider determines you need a controlled medication, they’ll likely refer you to an in-person specialist.
While federal law sets the baseline, individual states have their own telehealth regulations. The good news? Most states have made permanent the pandemic-era flexibilities that allow telehealth exams to count as valid medical evaluations before prescribing.
The majority of states—including California, New York, Texas, Florida, Michigan, Wisconsin, and South Carolina—do not require an in-person visit for non-controlled medications prescribed via telehealth. As long as the provider conducts an appropriate evaluation (which can be done entirely via video), they can legally prescribe Topamax or Wellbutrin.
California, for example, updated its law in 2025 to explicitly allow even asynchronous telehealth (like questionnaires and secure messaging) to constitute a valid exam if it meets the standard of care.
A handful of states—notably Alabama, Georgia, and New Hampshire—require a periodic in-person visit if telehealth treatment continues long-term:
Alabama: If you have more than four telehealth visits for the same condition within 12 months, you must have an in-person exam within that year (though this can be with any collaborating provider, not necessarily your telehealth prescriber).
Georgia: Providers must attempt an in-person exam at least annually for ongoing telemedicine care.
New Hampshire: For controlled substances prescribed via telehealth, an in-person follow-up is required every 12 months (this doesn’t apply to non-controlled BED medications, but it’s worth noting if your treatment plan evolves).
Even in these states, you can start treatment entirely online—the periodic visit requirement only kicks in for continued long-term care.
Telehealth prescribing isn’t limited to physicians. Nurse practitioners (NPs) and physician assistants (PAs) can also prescribe Topamax and Wellbutrin, though the level of autonomy varies by state:
Full Practice Authority States (34 states + DC): NPs can evaluate, diagnose, and prescribe independently without physician oversight. Recent additions to this list include Wisconsin, Michigan, Louisiana, and Kansas (all granted NP independence in 2023–2025).
Reduced/Collaborative Practice States: NPs and PAs must work under a collaborative agreement with a physician. This is common in states like Texas, Florida, Georgia, and Alabama. The physician doesn’t need to be present during your appointment, but they oversee the NP’s prescribing authority behind the scenes.
Restricted Practice States: Very few states heavily restrict NP prescribing, and these limitations rarely affect non-controlled medications like those used for BED.
When choosing a telehealth provider, it’s helpful to know that Klarity Health works with licensed physicians, nurse practitioners, and physician assistants across multiple states, ensuring you receive care from a qualified provider who can legally prescribe in your location.
A legitimate telehealth evaluation for binge eating disorder should feel very similar to an in-person appointment—just conducted via video. Here’s what a typical process looks like:
Your provider will ask detailed questions about:
To meet the DSM-5 criteria for BED, you must experience:
Your provider will screen for conditions that might make certain medications unsafe:
For Wellbutrin (Bupropion):
For Topamax (Topiramate):
If medication is appropriate, your provider will:
Most reputable providers will also discuss non-medication approaches, such as cognitive behavioral therapy (CBT), dialectical behavior therapy (DBT), and working with a registered dietitian—because medication works best as part of a comprehensive treatment plan.
Your provider will document that:
All of this goes into a secure, HIPAA-compliant electronic health record, just as it would in an in-person clinic.
Many states require prescribers to check the Prescription Drug Monitoring Program (PDMP) database before prescribing controlled substances. This is a state-run database that tracks prescriptions for opioids, stimulants, benzodiazepines, and other controlled medications to prevent ‘doctor shopping’ and overprescribing.
For Topamax and Wellbutrin: Since these are not controlled substances, most states do not mandate a PDMP check before prescribing them. However, responsible telehealth providers may still review your medication history as a safety precaution—for example, to ensure you’re not already taking another form of bupropion (which could lead to overdose) or to check for potential drug interactions.
This is considered good clinical practice, even when not legally required. Don’t be surprised if your provider asks about other medications you’re taking—it’s a sign they’re being thorough.
Once your provider writes a prescription, they’ll send it electronically to a pharmacy of your choice. Here’s what you should know:
Be cautious of telehealth platforms that ship medication directly to your door from their own warehouse without using a licensed pharmacy. While some legitimate compounding pharmacies do this, it can be a red flag. FDA-approved medications should come through a licensed pharmacy, ensuring you receive the correct, quality-controlled medication.
Because Topamax and Wellbutrin are non-controlled, your provider can often authorize refills for several months (up to 6–12 months depending on state law). However, you should still expect:
Consistent follow-up is crucial. These medications require monitoring for side effects, and your provider needs to assess whether the treatment is helping reduce your binge eating episodes.
The telehealth industry has grown rapidly, and while most providers are legitimate, there have been high-profile cases of unsafe prescribing (like the ADHD telehealth company whose executives were indicted for improperly prescribing Adderall). Here’s how to protect yourself:
Avoid providers who:
Look for services that:
Klarity Health, for instance, offers transparent pricing, accepts both insurance and self-pay, and ensures that all providers are licensed in your state. You’ll have access to experienced psychiatrists and psychiatric nurse practitioners who take the time to understand your unique situation.
One of the advantages of telehealth is often lower cost compared to in-person specialist visits, especially if you’re paying out of pocket. However, coverage varies:
If you don’t have insurance or prefer not to use it:
Klarity Health accepts both insurance and cash pay, giving you flexibility in how you access care. Their transparent pricing means you’ll know costs upfront, with no surprise bills.
While medication can be a valuable tool in managing BED, research consistently shows that the best outcomes come from a multi-faceted approach:
Working with a registered dietitian can help you:
Many telehealth platforms, including Klarity Health, can connect you with therapists in addition to prescribers, making it easy to access comprehensive care in one place.
While telehealth BED treatment is safe and effective for most people, certain populations require additional considerations:
Topiramate is not recommended during pregnancy due to the risk of birth defects, particularly cleft palate. If you’re pregnant, planning to become pregnant, or breastfeeding, your provider will likely focus on therapy-based interventions or choose medications with better safety profiles.
Bupropion has less clear pregnancy data but is generally used with caution. Always discuss pregnancy plans with your provider.
The FDA requires a black-box warning on antidepressants (including bupropion) about increased risk of suicidal thoughts in people under 25. This doesn’t mean the medication can’t be used, but it requires:
If you have a history of anorexia or bulimia, bupropion is contraindicated due to seizure risk. Your provider will need to carefully assess your full eating disorder history before prescribing.
If you have uncontrolled diabetes, severe obesity with complications, significant cardiovascular disease, or neurological conditions, your provider may require additional in-person evaluation or specialist consultation before starting medication.
The telehealth landscape continues to evolve. Here are the most recent developments as of early 2026:
These updates generally expand access to telehealth mental health care. The trend is clearly toward making telehealth a permanent, regulated, and accessible option for conditions like BED—especially for non-controlled medications.
Ready to take the first step? Here’s how to begin:
Look for platforms that:
Most platforms allow you to book online within days (or even the same day). You’ll need:
The more open you are about your eating patterns, mental health history, and concerns, the better your provider can help. This includes:
Starting medication is just the beginning. Plan to:
Finding the right medication and dose can take time. Topiramate, for example, requires slow titration over several weeks. Don’t get discouraged if you don’t see immediate results—consistent treatment and follow-up lead to the best outcomes.
If you’re considering telehealth for binge eating disorder, Klarity Health offers several advantages:
Binge eating disorder can feel isolating and overwhelming, but effective treatment is more accessible than ever thanks to telehealth. Whether you choose medication, therapy, or a combination approach, the most important step is reaching out for help.
You don’t have to struggle alone. With telehealth, you can connect with experienced providers who understand BED and can offer evidence-based treatment from the comfort and privacy of your home. The regulatory landscape is clear: telehealth prescribing for non-controlled medications like Topamax and Wellbutrin is legal, safe, and widely available across the United States.
If you’re ready to start your journey toward recovery, schedule an evaluation with Klarity Health today. Their team of compassionate providers is ready to help you develop a personalized treatment plan that works for your unique needs and circumstances.
Can I get BED medication prescribed online without an in-person visit?
Yes, for non-controlled medications like Topamax (topiramate) and Wellbutrin (bupropion), federal law and most state laws allow providers to prescribe after a thorough telehealth evaluation. You do not need an in-person visit to start treatment in most states.
Will my insurance cover telehealth appointments for BED?
Most insurance plans now cover telehealth mental health visits at the same rate as in-person visits. Check with your specific insurer, but coverage is generally good. Klarity Health accepts most major insurance plans and can verify your benefits before your appointment.
Are Topamax and Wellbutrin FDA-approved for binge eating disorder?
No, they are prescribed ‘off-label’ for BED. Topamax is FDA-approved for seizures and migraines, while Wellbutrin is approved for depression and smoking cessation. However, off-label prescribing is legal, common, and supported by clinical research showing these medications can help reduce binge eating episodes.
How long does it take for BED medications to work?
This varies by individual and medication. Wellbutrin may show effects within 2–4 weeks, while topiramate requires slow dose titration and may take 6–8 weeks to reach an effective dose. Consistency is key—don’t give up if you don’t see immediate results.
What are the most common side effects?
For Wellbutrin: dry mouth, headache, insomnia, nausea, and increased anxiety initially. For Topamax: tingling in hands/feet, cognitive changes (difficulty finding words, memory issues), changes in taste (carbonated drinks may taste flat), and weight loss. Always discuss side effects with your provider.
Do I need to check a prescription monitoring database for these medications?
No, as a patient you don’t need to do anything. Your provider may check the state prescription monitoring program as a safety measure, but since these medications are not controlled substances, it’s not legally required in most states.
Can nurse practitioners prescribe BED medication via telehealth?
Yes, nurse practitioners can prescribe these medications via telehealth in all 50 states. In about 34 states, NPs have full practice authority and can prescribe independently. In other states, they prescribe under a collaborative agreement with a physician, which doesn’t affect your access to care.
What if I’m pregnant or planning to become pregnant?
Topiramate is not recommended during pregnancy due to birth defect risks. Inform your provider immediately if you’re pregnant, planning to become pregnant, or not using effective contraception. Alternative treatments (like therapy-focused approaches) will be recommended.
Verified as of: January 4, 2026
DEA Rules Status: COVID-19 telehealth prescribing flexibilities remain in effect through December 31, 2026 (fourth extension). No federal in-person requirement exists for non-controlled medications.
States Verified: Researched 10+ key states (AL, CA, DE, FL, GA, NH, NY, TX, MI, WI, etc.) with latest information as of late 2025. State board sites and 2025 legislative updates were checked where available.
Sources Newer Than 2024: 80%+ of sources are from 2025 (many late-2025) or updated to 2025. Older sources (2024) were used only when confirmed still accurate by newer references.
Flagged for Follow-Up: Alabama and South Carolina NP scope changes (legislation was discussed in 2025 but final status unclear—assume no full independence yet pending confirmation). Monitor DEA’s pending final rule on telehealth prescribing (expected by end of 2026). Verify any temporary state waivers for expiration/extension beyond 2025.
U.S. Department of Health and Human Services. (2026, January). DEA extends telemedicine prescribing flexibilities through December 31, 2026. HHS.gov. https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html
Sheppard Mullin Richter & Hampton LLP. (2025, August). Telehealth and in-person visits: Tracking federal and state updates to pandemic-era telehealth exceptions. Sheppard Health Law Blog. https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/
Center for Connected Health Policy. (2025, November-December). State telehealth laws: Online prescribing. CCHP Telehealth Policy Database. https://www.cchpca.org/topic/online-prescribing/
Health Jobs Nationwide. (2025). State-by-state guide: Expanding roles for PAs and NPs (Updated 2025). Blog.HealthJobsNationwide.com. https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/
National Institutes of Health – DailyMed. (2024). Bupropion hydrochloride extended-release tablets – FDA label. DailyMed.NIH.gov. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=1b69c253-4740-44b0-be63-6c20834540b6&type=display
Find the right provider for your needs — select your state to find expert care near you.